치매에서의 행동 및 심리 증상에 대한 약물치료

키워드

참고문헌 (55)

1. Fairburn CG, "Changes in behaviour in dementia: a neglected research area", Br J Psychiatry, 152, pp.406~407 (1988)
2. O’Donnell BF, "Incontinence and troublesome behaviors predict institutionalization in dementia", J Geriatr Psychiatry Neurol, 5, pp.45~52 (1992)
3. Cohen-Mansfield J, "Assessment of disruptive behavior", agitation in the elderly: function, methods, and difficulties, 1995, pp.8, 52~60
4. Rabins PV, "The impact of dementia on the family", JAMA, 248, pp.333~335 (1982)
5. Tariot PN, "Treatment strategies for agitation and psychosis in dementia", J Clin Psychiatry, 57(Suppl 14), pp.21~29 (1996)
6. Malone ML, "Aggressive behaviors among the institutionalized elderly", J Am Geriatr Soc, 41, pp.853~856 (1993)
7. Borson S, "Clinical features and pharmacologic treatment of behavioral symptoms of Alzheimer’s disease", Neurology, 48(5 Suppl 6), pp.S17~S24 (1997)
8. Gallagher-Thompson D, "The relations among caregiver stress, “sundowning” symptoms, and cognitive decline in Alzheimer’s disease", J Am Geriatr Soc, 40, pp.807~810 (1992)
9. Rada RT, "Thiothixene in the treatment of geriatric patients with chronic organic brain syndrome", J Am Geriatr Soc, 24, pp.105~107 (1976)
10. Tariot PN, "Treatment of agitation in dementia", J Clin Psychiatry, 60(Suppl 8), pp.11~20 (1999)
11. Risse SC, "Pharmacologic treatment of agitation associated with dementia", J Am Geriatr Soc, 34, pp.368~376 (1986)
12. Lanctôt KL, "Efficacy and safety of neuroleptics in behavioral disorders associated with dementia", J Clin Psychiatry, 59, pp.550~561 (1998)
13. Schneider LS, "A metaanalysis of controlled trials of neuroleptic treatment in dementia", J Am Geriatr Soc, 38, pp.553~563 (1990)
14. Lonergan E, "Haloperidol for agitation in dementia", Cochrane Database Syst Rev, (2), pp.CD002852~ (2002)
15. Pitner JK, "Efficacy and adverse effects of clozapine in four elderly psychotic patients", J Clin Psychiatry, 56, pp.180~185 (1995)
16. Musser WS, "Clozapine as a treatment for psychosis in Parkinson’s disease: a review", J Neuropsychiatry Clin Neurosci, 8, pp.1~9 (1996)
17. Burke WJ, "Neuroleptic sensitivity to clozapine in dementia with Lewy bodies", J Neuropsychiatry Clin Neurosci, 10, pp.227~229 (1998)
18. Katz IR, "Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, doubleblind trial. Risperidone Study Group", J Clin Psychiatry, 60, pp.107~115 (1999)
19. Jeste DV, "Management of late-life psychosis", J Clin Psychiatry, 57(Suppl 3), pp.39~45 (1996)
20. Lavretsky H, "A structured trial of risperidone for the treatment of agitation in dementia", Am J Geriatr Psychiatry, 6, pp.127~135 (1998)
21. Schneider LS, "Effectiveness of atypical antipsychotic drugs in patients with Alzheimer’s disease", N Engl J Med, 355, pp.1525~1538 (2006)
22. Bullock R, "Treatment of behavioural and psychiatric symptoms in dementia: implications of recent safety warnings", Curr Med Res Opin, 21, pp.1~10 (2005)
23. Burke AD, "Atypical antipsychotics in the elderly: a review of therapeutic trends and clinical outcomes", Expert Opin Pharmacother, 10, pp.2407~2414 (2009)
24. Street JS, "Long-term efficacy of olanzapine in the control of psychotic and behavioral symptoms in nursing home patients with Alzheimer’s dementia", Int J Geriatr Psychiatry, 16(Suppl 1:), pp.S62~S70 (2001)
25. Street JS, "Olanzapine treatment of psychotic and behavioral symptoms in patients with Alzheimer disease in nursing care facilities: a double-blind, randomized, placebo-controlled trial. The HGEU Study Group", Arch Gen Psychiatry, 57, pp.968~976 (2000)
26. Aarsland D, "Olanzapine for psychosis in patients with Parkinson’s disease with and without dementia", J Neuropsychiatry Clin Neurosci, 11, pp.392~394 (1999)
27. Zhong KX, "Quetiapine to treat agitation in dementia: a randomized, double-blind, placebo-controlled study", Curr Alzheimer Res, 4, pp.81~93 (2007)
28. Fernandez HH, "Quetiapine for the treatment of drug-induced psychosis in Parkinson’s disease", Mov Disord, 14, pp.484~487 (1999)
29. Jeste DV, "Psychosis of Alzheimer’s disease and related dementias. Diagnostic criteria for a distinct syndrome", Am J Geriatr Psychiatry, 8, pp.29~34 (2000)
30. Mintzer JE, "Aripiprazole for the treatment of psychoses in institutionalized patients with Alzheimer dementia: a multicenter, randomized, double-blind, placebo-controlled assessment of three fixed doses", Am J Geriatr Psychiatry, 15, pp.918~931 (2007)
31. Patel S, "Pharmacologic models of Alzheimer’s disease", Psychiatr Clin North Am, 14, pp.287~308 (1991)
32. Tariot PN, "The Behavior Rating Scale for Dementia of the Consortium to Establish a Registry for Alzheimer’s Disease. The Behavioral Pathology Committee of the Consortium to Establish a Registry for Alzheimer’s Disease", Am J Psychiatry, 152, pp.1349~1357 (1995)
33. Coccaro EF, "Neurotransmitter correlates of impulsive aggression in humans", Ann N Y Acad Sci, 794, pp.82~89 (1996)
34. Sultzer DL, "A double-blind comparison of trazodone and haloperidol for treatment of agitation in patients with dementia", Am J Geriatr Psychiatry, 5, pp.60~69 (1997)
35. Alexopoulos GS, "The expert consensus guideline series. Treatment of dementia and its behavioral disturbances. Introduction: methods, commentary, and summary", Postgrad Med, pp.6~22 (2005)
36. Nyth AL, "The clinical efficacy of citalopram in treatment of emotional disturbances in dementia disorders. A Nordic mul-ticentre study", Br J Psychiatry, 157, pp.894~901 (1990)
37. Ragneskog H, "Long-term treat-ment of elderly individuals with emotional disturbances: an open study with citalopram", Int Psychogeriatr, 8, pp.659~668 (1996)
38. Pollock BG, "An open pilot study of citalopram for behavioral disturbances of dementia. Plasma levels and real-time observations", Am J Geriatr Psychiatry, 5, pp.70~78 (1997)
39. Pollock BG, "Comparison of citalopram, perphenazine, and placebo for the acute treatment of psychosis and behavioral disturbances in hospitalized, demented patients", Am J Psychiatry, 159, pp.460~465 (2002)
40. Pollock BG, "A double-blind comparison of citalopram and risperidone for the treatment of behavioral and psychotic symptoms associated with dementia", Am J Geriatr Psychiatry, 15, pp.942~952 (2007)
41. Tariot PN, "Carbamazepine treatment of agitation in nursing home patients with dementia: a preliminary study", J Am Geriatr Soc, 42, pp.1160~1166 (1994)
42. Tariot PN, "Lack of carbamazepine toxicity in frail nursing home patients: a controlled study", J Am Geriatr Soc, 43, pp.1026~1029 (1995)
43. Tariot PN, "Anticonvulsant and other non-neuroleptic treatment of agitation in dementia", J Geriatr Psychiatry Neurol, 8(Suppl 1), pp.S28~S39 (1995)
44. Narayan M, "Treatment of dementia with behavioral disturbance using divalproex or a combination of divalproex and a neuroleptic", J Clin Psychiatry, 58, pp.351~354 (1997)
45. Sival RC, "Sodium valproate in the treatment of aggressive behavior in patients with dementia--a randomized placebo controlled clinical trial", Int J Geriatr Psychiatry, 17, pp.579~585 (2002)
46. Tariot PN, "Divalproex sodium in nursing home residents with possible or probable Alzheimer Disease complicated by agitation: a randomized, controlled trial", Am J Geriatr Psychiatry, 13, pp.942~949 (2005)
47. Regan WM, "Gabapentin for behavioral agitation in Alzheimer’s disease", J Clin Psychopharmacol, 17, pp.59~60 (1997)
48. Hawkins JW, "A retrospective chart review of gabapentin for the treatment of aggressive and agitated behavior in patients with dementias", Am J Ge-riatr Psychiatry, 8, pp.221~225 (2000)
49. Megna JL, "Gabapentin’s effect on agitation in severely and persistently mentally ill patients", Ann Pharmacother, 36, pp.12~16 (2002)
50. Birks J, "Cholinesterase inhibitors for Alzheimer’s disease", Coch-rane Database Syst Rev, (1), pp.CD005593~ (2006)
51. Cummings JL, "Donepezil-Sertraline Study Group. Effects of donepezil on neuropsychiatric symptoms in patients with dementia and severe behavioral disorders", Am J Geriatr Psychiatry, 14, pp.605~612 (2006)
52. Wilcock GK, "Memantine for agitation", aggression and psychosis in moderately severe to severe Alzheimer’s disease: a pooled analysis of 3 studies, 2008, pp.69, 341~348
53. McShane R, "Memantine for dementia", Cochrane Database Syst Rev, 2, pp.CD003154~ (2006)
54. Peskind ER, "Propranolol for disruptive behaviors in nursing home residents with probable or possible Alzheimer disease: a placebo-controlled study", Alzheimer Dis Assoc Disord, 19, pp.23~28 (2005)
55. Wang LY, "Prazosin for the treatment of behavioral symptoms in patients with Alzheimer disease with agitation and aggression", Am J Geriatr Psychiatry, 17, pp.744~751 (2009)

관련 논문AI추천